Testing effectiveness (Phase 2)Ended earlyNCT03320876
What this trial is testing
An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.
Who this might be right for
Psoriatic Arthritis
Lakefront Biotherapeutics NV 122